Dr. Barry E. Storer

powered by
COS Expertise®
Fred Hutchinson Cancer Research Center
Clinical Statistics
Clinical Research
MemberAppointed: 1995
University of Washington
School of Public Health and Community Medicine
Biostatistics
Affiliate ProfessorAppointed: 1996
Fred Hutchinson Cancer Research Center
Public Health Sciences
MemberAppointed: 1995
Professional Headshot of Barry E. Storer

Mailing Address

Fred Hutchinson Cancer Research Center
1100 Fairview Avenue N., D5-360
P.O. Box 19024
Seattle, Washington 98109-1024
United States

Contact Information

Phone: (206) 667-6151
Fax: (206) 667-6358
bstorer@fhcrc.org

Qualifications

Ph.D., University of Washington, Biostatistics, 1984.
M.A., University of Montana, Zoology, 1977.
B.A., University of New Hampshire, Zoology, 1973.

Expertise and Research Interests

Biostatistical Methods And Applications In Clinical Trials And Epidemiology.

Although considerable attention has been paid to the design and analysis of Phase III clinical trials (randomized controlled trials of efficacy), relatively less effort has been directed to Phase II (uncontrolled trials of efficacy, often with surrogate endpoints) and especially Phase I (dose-finding trials evaluating toxicity) clinical trials. I have collaborated for many years with clinicians conducting Phase I clinical trials of anti-cancer agents, both traditional cytotoxic drugs and biological agents.

In typical designs for such studies, a starting dose level and a sequence of increasing dose levels thereafter are determined based on the results of toxicity trials in animals. Small cohorts of patients (3-6 per dose level) are entered beginning at the first dose level. Subsequent cohorts are entered either at the next higher dose level, or the trial is stopped, depending on the toxicity experience in the current cohort, according to a predetermined algorithm.

One of my research interests has been to evaluate the operating characteristics of designs of this type and to consider designs that differ from the standard. The operating characteristics of a design unfortunately depend to a large extent on the true dose-toxicity curve, which is unknown; however, Monte Carlo simulations conducted over a wide range of plausible dose-response settings can provide useful information regarding the performance of the design and enable a clinician to choose a particular design based on objective characteristics.

Here at the Fred Hutchinson Cancer Research Center, some Phase I trials in the stem cell transplant program can be designed to address dose-finding with respect to both toxicity and efficacy in the same patient population. For example, a drug used to prevent graft versus host disease (GVHD) may be more effective at a higher dose but also have greater toxicity, and the goal is to find a dose that achieves a desirable combination of efficacy and safety. The design of such trials is of interest to myself and other statisticians in the Clinical Research Division.

Other methodologic work has focused on the design of Phase II trials, as well as diagnostics for identifying unusually influential observations in regression analysis.

Keywords

COS Keywords:

Biostatistics, Clinical Trial, Epidemiology.

Memberships

American Statistical Association
Biometric Society
Society for Clinical Trials

Previous Positions

1992-1995, Associate Professor, University of Wisconsin, Statistics, Biostatistics
1990-1992, Associate Professor, University of Wisconsin, Statistics, Human Oncology
1984-1995, Member, University of Wisconsin, Comprehensive Cancer Center
1984-1990, Assistant Professor, University of Wisconsin, Statistics, Human Oncology
1981-1983, Research Associate, Fred Hutchinson Cancer Research Center, National Wilms Tumor Study
1979-1981, Research Associate, University of Washington, School of Public Health and Community Medicine, Biostatistics
-1984, Assistant Staff Scientist, Fred Hutchinson Cancer Research Center, Public Health Sciences

Publications

  • Stewart FM, Wasserman R, Bloomfield C, Petersdorf S, Witherspoon R, Appelbaum F, Ziskind A, McKenna B, Dodson J, Weeks J, Vaughan W, Storer B, Perkel S, Waldinger M (2006) Benchmarks in clinical productivity: An NCCN survey, Journal of Oncology Practice, In Press
  • Scott BL, Storer BE, Greene JE, Hackman RC, Appelbaum FR, Deeg HJ (2006) Marrow fibrosis as a risk factor for post-transplant outcome in patients with advanced MDS or AML with multilineage dysplasia, Biology of Blood and Marrow Transplantation, In Press
  • Deeg HJ, O'Donnell M, Tolar J, Agarwal R, Harris RE, Feig SA, Territo MC, Collins RH, McSweeney PA, Copelan EA, Khan SP, Woolfrey A, Storer B (2006) Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy, Blood, 108, 1485-1491
  • Baron F, Storer B, Maris MB, Storek J, Piette F, Metcalf M, White K, Sandmaier BM, Maloney DG, Storb R, Boeckh M (2006) Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning, Biology of Blood and Marrow Transplantation, 12 (11), 1176-1187
  • Baron F, Storb R, Storer BE, Maris MB, Niederwieser D, Shizuru JA, Chauncey TR, Bruno B, Forman SJ, McSweeney PA, Maziarz RT, Pulsipher MA, Agura ED, Wade J, Sorror M, Maloney DG, Sandmaier BM (2006) Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation, Journal of Clinical Oncology, 24 (25), 4150-4157
  • Deeg HJ, Storer BE, Boeckh M, Martin PJ, McCune JS, Myerson D, Heimfeld S, Flowers ME, Anasetti C, Doney KC, Hansen JA, Kiem H-P, Nash RA, O'Donnell PV, Radich JP, Sandmaier BM, Scott BL, Sorror ML, Warren EH, Witherspoon RP, Woolfrey A, Appelbaum FR, Storb R (2006) Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen, Biology of Blood and Marrow Transplantation, 12 (5), 573-584
  • Yunusov MY, Kuhr CS, Georges GE, Hogan WJ, Taranova AG, Lesnikova M, Kim Y-S, Abrams K, Hwang B, Sale GE, Storer B, Storb R, Nash RA (2006) Partial donor-specific tolerance to delayed skin grafts after rejection of hematopoietic cell graft, Transplantation, 82 (5), 629-637
  • Maris MB, Sandmaier BM, Storer BE, Maloney DG, Shizuru JA, Agura E, Kliem C, Pulsipher M, Maziarz RT, McSweeney PA, Wade J, Langston AA, Chauncey TR, Bruno B, Blume KG, Storb R (2006) Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: The effect of postgrafting mycophenolate mofetil dosing, Biology of Blood and Marrow Transplantation, 12 (4), 454-465
  • Baron F, Sandmaier BM, Zellmer E, Sorror M, Storer B, Storb R (2006) Failure of donor lymphocyte infursion to prevent graft rejection in dogs given DLA-identical marrows after 1 Gy of total body irradiation, Biology of Blood and Marrow Transplantation, 12 (8), 813-817
  • Zhang X-B, Beard BC, Beebe K, Storer B, Humphries RK, Kiem H-P (2006) Differential effects of HOXB4 on nonhuman primate short- and long-term repopulating cells, PLoS Medicine, 3 (5), 0687-0698
  • Wang H-M, Jones MP, Storer BE (2006) Comparison of case-deletion diagnostic methods for Cox regression, Statistics in Medicine, 25 (4), 669-683
  • Hegenbart U, Niederwieser D, Sandmaier BM, Maris MB, Shizuru JA, Greinix H, Cordonnier C, Rio B, Gratwohl A, Lange T, Al-Ali H, Storer B, Maloney D, McSweeney P, Chauncey T, Agura E, Bruno B, Maziarz RT, Peterson F, Storb R (2006) Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hemaopoietic cell transplantation from related and unrelated donors, Journal of Clinical Oncology, 24 (3), 444-453
  • Scott BL, Sandmaier BM, Storer B, Maris MB, Sorror ML, Maloney DG, Chauncey TR, Storb R, Deeg HJ (2006) Myeloablative vs. nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: A retrospective analysis, Leukemia, 20, 128-135
  • Weiss AS, Sandmaier BM, Storer B, Storb R, McSweeney PA, Parikh CR (2006) Chronic kidney disease following nonmyeloablative hematopoietic cell transplantation, American Journal of Transplantation, 6, 89-94
  • Hoffmeister PA, Madtes DK, Storer BE, Sanders JE (2006) Pulmonary function in long-term survivors of pediatric hematopoietic cell transplantation, Pediatric Blood and Cancer, 47 (5), 594-606
  • Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B (Oct 2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT., Blood, 106 (8), 2912-9 Abstract
  • Syrjala KL, Langer SL, Abrams JR, Storer BE, Martin PJ (Sep 2005) Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls., Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 23 (27), 6596-606 Abstract
  • Carpenter PA, Lowder J, Johnston L, Frangoul H, Khoury H, Parker P, Jerome KR, McCune JS, Storer B, Martin P, Appelbaum F, Abonour R, Westervelt P, Anasetti C (Jun 2005) A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 11 (6), 465-71 Abstract
  • Baron F, Maris MB, Storer BE, Sandmaier BM, Panse JP, Chauncey TR, Sorror M, Little MT, Maloney DG, Storb R, Heimfeld S (May 2005) High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transpl, Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 19 (5), 822-8 Abstract
  • Baron F, Maris MB, Storer BE, Sandmaier BM, Stuart MJ, McSweeney PA, Radich JP, Pulsipher MA, Agura ED, Chauncey TR, Maloney DG, Shizuru JA, Storb R (Apr 2005) HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 11 (4), 272-9 Abstract
  • Baron F, Maris MB, Sandmaier BM, Storer BE, Sorror M, Diaconescu R, Woolfrey AE, Chauncey TR, Flowers ME, Mielcarek M, Maloney DG, Storb R (Mar 2005) Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning., Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 23 (9), 1993-2003 Abstract
  • Panse JP, Heimfeld S, Guthrie KA, Maris MB, Maloney DG, Baril BB, Little MT, Chauncey TR, Storer BE, Storb R, Sandmaier BM (Mar 2005) Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning., British Journal of Haematology, 128 (5), 659-67 Abstract
  • Parikh CR, Schrier RW, Storer B, Diaconescu R, Sorror ML, Maris MB, Maloney DG, McSweeney P, Storb R, Sandmaier BM (Mar 2005) Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation., American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation., 45 (3), 502-9 Abstract
  • Flowers ME, Traina F, Storer B, Maris M, Bethge WA, Carpenter P, Appelbaum F, Storb R, Sandmaier BM, Martin PJ (Feb 2005) Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning., Bone Marrow Transplantation, 35 (3), 277-82 Abstract
  • Lin M-T, Storer B, Martin PJ, Tseng L-H, Grogan B, Chen P-J, Zhao LP, Hansen JA (2005) Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor-ß genotype of donor, Blood, 106 (12), 3995-4001
  • Panse JP, Storb R, Storer B, Santos EB, Wentzel C, Sandmaier BM (2005) Prolonged allogeneic marrow engraftment following nonmyeloablative conditioning using 100 cGy total body irradiation and pentostatis before and pharmacological immunosuppression after transplantation, Transplantation, 80 (10), 1518-1521
  • Sangiolo D, Storer B, Nash R, Corey L, Davis C, Flowers M, Hackman RC, Boeckh M (2005) Toxicity and efficacy of daily Dapsone as pneumocystis jiroveci prophylaxis after hematopoietic stem cell transplantation: A case-control study, Biology of Blood and Marrow Transplantation, 11, 521-529
  • Nash RA, Johnston L, Parker P, McCune JS, Storer B, Slattery JT, Furlong T, Anasetti C, Appelbaum FR, Lloid ME, Deeg HJ, Kiem H-P, Martin PJ, Schubert MM, Witherspoon RP, Forman SJ, Blume KG, Storb R (2005) Phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation, Biology of Blood and Marrow Transplantation, 11, 495-505
  • Carpenter PA, Lowder J, Johnston L, Frangoul H, Khoury H, Parker P, Jerome KR, McCune JS, Storer B, Martin P, Appelbaum F, Abonour R, Westervelt P, Anasetti C (2005) A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory actue graft-versus-host disease, Biology of Blood and Marrow Transplantation, 11 (6), 465-471
  • Sorror ML, Maris MB, Sandmaier BM, Storer BE, Stuart MJ, Hegenbart U, Agura E, Chauncey TR, Leis J, Pulsipher M, McSweeney P, Radich JP, Bredeson C, Bruno B, Langston A, Loken MR, Al-Ali H, Blume KG, Storb R, Maloney DG (2005) Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia, Journal of Clinical Oncology, 23 (16), 3819-3829
  • Scott BL, Storer B, Loken MR, Storb R, Appelbaum FR, Deeg HJ (Jan 2005) Pretransplantation induction chemotherapy and posttransplantation relapse in patients with advanced myelodysplastic syndrome., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 11 (1), 65-73 Abstract
  • Kahl C, Mielcarek M, Iwata M, Harkey MA, Storer B, Torok-Storb B (Dec 2004) Radiation dose determines the degree of myeloid engraftment after nonmyeloablative stem cell transplantation., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 10 (12), 826-33 Abstract
  • Scott B, Deeg HJ, Storer B, Chauncey T, Petersdorf S, Slattery J, Appelbaum F (Dec 2004) Targeted busulfan and cyclophosphamide as compared to busulfan and TBI as preparative regimens for transplantation in patients with advanced MDS or transformation to AML., Leukemia & Lymphoma, 45 (12), 2409-17 Abstract
  • Stewart BL, Storer B, Storek J, Deeg HJ, Storb R, Hansen JA, Appelbaum FR, Carpenter PA, Sanders JE, Kiem HP, Nash RA, Petersdorf EW, Moravec C, Morton AJ, Anasetti C, Flowers ME, Martin PJ (Dec 2004) Duration of immunosuppressive treatment for chronic graft-versus-host disease., Blood, 104 (12), 3501-6 Abstract
  • Maris MB, Sandmaier BM, Storer BE, Chauncey T, Stuart MJ, Maziarz RT, Agura E, Langston AA, Pulsipher M, Storb R, Maloney DG (Dec 2004) Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma., Blood, 104 (12), 3535-42 Abstract
  • Diaconescu R, Flowers CR, Storer B, Sorror ML, Maris MB, Maloney DG, Sandmaier BM, Storb R (Sep 2004) Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors., Blood, 104 (5), 1550-8 Abstract
  • Sorror ML, Maris MB, Storer B, Sandmaier BM, Diaconescu R, Flowers C, Maloney DG, Storb R (Aug 2004) Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities., Blood, 104 (4), 961-8 Abstract
  • Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers ME, Martin PJ, Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma, Jama: The Journal of the American Medical Association, 291(19), 2335-43, May 2004
  • Forouzannia A, Schiller J, Berlin J, Hutson P, Boothman D, Storer B, Wilding G, Mehta M (Apr 2004) A phase I study of Topotecan, as a radiosensitizer, for thoracic malignancies., Lung Cancer (amsterdam, Netherlands), 44 (1), 111-9 Abstract
  • Hoffmeister PA, Storer BE, Sanders JE, Diabetes mellitus in long-term survivors of pediatric hematopoietic cell transplantation, Journal of Pediatric Hematology/oncology: Official Journal of the American Society of Pediatric Hematology/oncology, 26(2), 81-90, February 2004
  • Bethge WA, Hegenbart U, Stuart MJ, Storer BE, Maris MB, Flowers ME, Maloney DG, Chauncey T, Bruno B, Agura E, Forman SJ, Blume KG, Niederwieser D, Storb R, Sandmaier BM, Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning, Blood, 103(3), 790-5, February 2004 Abstract
  • Hogan WJ, Maris M, Storer B, Sandmaier BM, Maloney DG, Schoch HG, Woolfrey AE, Shulman HM, Storb R, McDonald GB, Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: A study of 193 patients, Blood, 103(1), 78-84, January 2004
  • Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ, Hansen JA, Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation, The New England Journal of Medicine, 349(23), 2201-10, December 2003 Abstract
  • Freudenberger TD, Madtes DK, Curtis JR, Cummings P, Storer BE, Hackman RC, Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants, Blood, 102(10), 3822-8, November 2003 Abstract
  • Maloney DG, Molina AJ, Sahebi F, Stockerl-Goldstein KE, Sandmaier BM, Bensinger W, Storer B, Hegenbart U, Somlo G, Chauncey T, Bruno B, Appelbaum FR, Blume KG, Forman SJ, McSweeney P, Storb R, Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma, Blood, 102(9), 3447-54, November 2003 Abstract
  • Storek J, Douek DC, Keesey JC, Boehmer L, Storer B, Maloney DG, Low T cell receptor excision circle levels in patients thymectomized 25-54 years ago, Immunology Letters, 89(2-3), 91-2, October 2003 Abstract
  • Bethge WA, Storer BE, Maris MB, Flowers ME, Maloney DG, Chauncey TR, Woolfrey AE, Storb R, Sandmaier BM, Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: Effect of interventions on outcome, Experimental Hematology, 31(10), 974-80, October 2003
  • Maris M, Boeckh M, Storer B, Dawson M, White K, Keng M, Sandmaier B, Maloney D, Storb R, Storek J, Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning, Experimental Hematology, 31(10), 941-52, October 2003 Abstract
  • Maris MB, Niederwieser D, Sandmaier BM, Storer B, Stuart M, Maloney D, Petersdorf E, McSweeney P, Pulsipher M, Woolfrey A, Chauncey T, Agura E, Heimfeld S, Slattery J, Hegenbart U, Anasetti C, Blume K, Storb R, HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies, Blood, 102(6), 2021-30, September 2003 Abstract
  • Bornhauser M, Storer B, Slattery JT, Appelbaum FR, Deeg HJ, Hansen J, Martin PJ, McDonald GB, Nichols WG, Radich J, Woolfrey A, Jenke A, Schleyer E, Thiede C, Ehninger G, Anasetti C, Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells, Blood, 102(3), 820-6, August 2003 Abstract
  • Goff BA, Thompson T, Greer BE, Jacobs A, Storer B, Puget Sound Oncology Consortium, Treatment of recurrent platinum resistant ovarian or peritoneal cancer with gemcitabine and doxorubicin: A phase I/II trial of the Puget Sound Oncology Consortium (PSOC 1602), American Journal of Obstetrics and Gynecology, 188(6), 1556-62; discussion, June 2003 Abstract
  • Moskovitz AH, Linford NJ, Brentnall TA, Bronner MP, Storer BE, Potter JD, Bell RH Jr, Rabinovitch PS, Chromosomal instability in pancreatic ductal cells from patients with chronic pancreatitis and pancreatic adenocarcinoma, Genes, Chromosomes & Cancer, 37(2), 201-6, June 2003 Abstract
  • Abrams K, Yunusov MY, Slichter S, Moore P, Nelp WB, Burstein SA, McDonough S, Durack L, Storer B, Storb R, Gass MJ, Georges G, Nash RA, Recombinant human macrophage colony-stimulating factor-induced thrombocytopenia in dogs, British Journal of Haematology, 121(4), 614-22, May 2003 Abstract
  • Newcomb PA, Storer BE, Morimoto LM, Templeton A, Potter JD, Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence, Journal of the National Cancer Institute, 95(8), 622-5, April 2003 Abstract
  • Newcomer LM, Newcomb PA, Potter JD, Yasui Y, Trentham-Dietz A, Storer BE, Longnecker MP, Baron JA, Daling JR, Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States), Cancer Causes & Control : Ccc, 14(3), 225-33, April 2003 Abstract
  • Storek J, Viganego F, Dawson MA, Herremans MM, Boeckh M, Flowers ME, Storer B, Bensinger WI, Witherspoon RP, Maloney DG, Factors affecting antibody levels after allogeneic hematopoietic cell transplantation, Blood, 101(8), 3319-24, April 2003 Abstract
  • Yunusov MY, Georges GE, Storb R, Moore P, Hagglund H, Affolter V, Lesnikova M, Gass MJ, Little MT, Loken M, McKenna H, Storer B, Nash RA, FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host disease, Transplantation, 75(7), 933-40, April 2003 Abstract
  • Niederwieser D, Maris M, Shizuru JA, Petersdorf E, Hegenbart U, Sandmaier BM, Maloney DG, Storer B, Lange T, Chauncey T, Deininger M, Ponisch W, Anasetti C, Woolfrey A, Little MT, Blume KG, McSweeney PA, Storb RF, Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppressio, Blood, 101(4), 1620-9, February 2003 Abstract
  • Newcomer LM, Newcomb PA, Trentham-Dietz A, Storer BE, Yasui Y, Daling JR, Potter JD, Detection method and breast carcinoma histology, Cancer, 95(3), 470-7, Aug 2002 Abstract
  • Deeg HJ, Storer B, Slattery JT, Anasetti C, Doney KC, Hansen JA, Kiem HP, Martin PJ, Petersdorf E, Radich JP, Sanders JE, Shulman HM, Warren EH, Witherspoon RP, Bryant EM, Chauncey TR, Getzendaner L, Storb R, Appelbaum FR, Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome, Blood, 100(4), 1201-7, Aug 2002 Abstract
  • Newcomb PA, Titus-Ernstoff L, Egan KM, Trentham-Dietz A, Baron JA, Storer BE, Willett WC, Stampfer MJ, Postmenopausal estrogen and progestin use in relation to breast cancer risk, Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology., 11(7), 593-600, July 2002 Abstract
  • Flowers ME, Parker PM, Johnston LJ, Matos AV, Storer B, Bensinger WI, Storb R, Appelbaum FR, Forman SJ, Blume KG, Martin PJ, Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial, Blood, 100(2), 415-9, July 2002 Abstract
  • Storek J, Joseph A, Dawson MA, Douek DC, Storer B, Maloney DG, Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation, Transplantation, 73(7), 1154-8, April 2002 Abstract
  • Woolfrey AE, Anasetti C, Storer B, Doney K, Milner LA, Sievers EL, Carpenter P, Martin P, Petersdorf E, Appelbaum FR, Hansen JA, Sanders JE, Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children, Blood, 99(6), 2002-8, March 2002 Abstract
  • Remberger M, Storer B, Ringden O, Anasetti C, Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors, Bone Marrow Transplantation, 29(5), 391-7, March 2002 Abstract
  • Xun CQ, Little MT, Zellmer E, Yu C, Zaucha JM, Sale GE, Storer B, Storb R, What role for FTY720, a novel immunosuppressive agent, in canine nonmyeloablative hematopoietic stem cell transplantation?, Transplantation, 73(2), 310-3, January 2002 Abstract
  • Jurado M, Deeg HJ, Storer B, Anasetti C, Anderson JE, Bryant E, Chauncey T, Doney K, Flowers ME, Hansen J, Martin PJ, Nash RA, Petersdorf E, Radich J, Sale G, Sandmaier BM, Storb R, Wade J, Witherspoon R, Appelhaum FR, Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate b, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 8(3), 161-9, 2002 Abstract
  • Petersdorf EW, Hansen JA, Martin PJ, Woolfrey A, Malkki M, Gooley T, Storer B, Mickelson E, Smith A, Anasetti C, Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation, The New England Journal of Medicine, 345(25), 1794-800, December 2001 Abstract
  • Newcomer LM, Newcomb PA, Trentham-Dietz A, Storer BE, Hormonal risk factors for endometrial cancer: modification by cigarette smoking (United States), Cancer Causes & Control : Ccc, 12(9), 829-35, November 2001 Abstract
  • Storer BE, An evaluation of phase I clinical trial designs in the continuous dose-response setting, Statistics in Medicine, 20(16), 2399-408, August 2001 Abstract
  • Storek J, Wells D, Dawson MA, Storer B, Maloney DG, Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation, Blood, 98(2), 489-91, July 2001 Abstract
  • Newcomb PA, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Baron JA, Storer BE, Willett WC, Stampfer MJ, Fracture history and risk of breast and endometrial cancer, American Journal of Epidemiology, 153(11), 1071-8, June 2001 Abstract
  • Storek J, Dawson MA, Storer B, Stevens-Ayers T, Maloney DG, Marr KA, Witherspoon RP, Bensinger W, Flowers ME, Martin P, Storb R, Appelbaum FR, Boeckh M, Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation, Blood, 97(11), 3380-9, June 2001 Abstract
  • Witherspoon RP, Deeg HJ, Storer B, Anasetti C, Storb R, Appelbaum FR, Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 19(8), 2134-41, April 2001 Abstract
  • Zaucha JM, Zellmer E, Georges G, Little MT, Storb R, Storer B, Torok-Storb B, G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 7(11), 613-9, 2001 Abstract
  • Boeckh M, Bowden RA, Storer B, Chao NJ, Spielberger R, Tierney DK, Gallez-Hawkins G, Cunningham T, Blume KG, Levitt D, Zaia JA, Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic st, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, 7(6), 343-51, 2001 Abstract
  • Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R, Kashyap A, Flowers ME, Lilleby K, Chauncey TR, Storb R, Appelbaum FR, Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers, The New England Journal of Medicine, 344(3), 175-81, Jan 2001 Abstract
  • Deeg HJ, Amylon ID, Harris RE, Collins R, Beatty PG, Feig S, Ramsay N, Territo M, Khan SP, Pamphilon D, Leis JF, Burdach S, Anasetti C, Hackman R, Storer B, Mueller B, Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, 7(4), 208-15, 2001 Abstract
  • Gooley T, Storer B, Press OW (2001) Statistical designs for clinical trials of radioimmunotherapy (Letter to the Editor), Blood, 98 (4), 1275-1276
  • Walters MC, Patience M, Leisenring W, Rogers ZR, Aquino VM, Buchanan GR, Roberts IA, Yeager AM, Hsu L, Adamkiewicz T, Kurtzberg J, Vichinsky E, Storer B, Storb R, Sullivan KM, Multicenter Investigation of Bone Marrow Transplantation for Sickle Cell Disease (2001) Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 7 (12), 665-73 Abstract
  • Gooley TA, Leisenring W, Crowley J, Storer BE (2001) Why Kaplan-Meier fails and cumulative incidence succeeds when estimating failure probabilities in the presence of competing risks, Handbook of Statistics in Clinical Oncology, New York, Marcel Dekker, Inc., 513-523 pages (bookchapter)
  • Storer BE (2001) Choosing a Phase I design, Handbook of Statistics in Clinical Oncology, New York, Marcel Dekker, Inc., 73-91 pages (bookchapter)
  • McNeel DG, Nguyen LD, Storer BE, Vessella R, Lange PH, Disis ML, Antibody immunity to prostate cancer associated antigens can be detected in the serum of patients with prostate cancer, Journal of Urology, 164(5), 1825-9, November 2000 Abstract
  • Storek J, Espino G, Dawson MA, Storer B, Flowers ME, Maloney DG, Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation, Blood, 96(9), 3290-3, November 2000 Abstract
  • Wagner JL, Storb R, Storer B, Mignot E, DLA-DQB1 alleles and bone marrow transplantation experiments in narcoleptic dogs, Tissue Antigens, 56(3), 223-31, September 2000 Abstract
  • Sierra J, Storer B, Hansen JA, Martin PJ, Petersdorf EW, Woolfrey A, Matthews D, Sanders JE, Storb R, Appelbaum FR, Anasetti C, Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience, Bone Marrow Transplantation, 26(4), 397-404, August 2000 Abstract
  • Trentham-Dietz A, Newcomb PA, Storer BE, Remington PL, Risk factors for carcinoma in situ of the breast, Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 9(7), 697-703, July 2000 Abstract
  • Trentham-Dietz A, Newcomb PA, Egan KM, Titus-Ernstoff L, Baron JA, Storer BE, Stampfer M, Willett WC, Weight change and risk of postmenopausal breast cancer (United States), Cancer Causes & Control : Ccc, 11(6), 533-42, July 2000 Abstract
  • Rudolph RE, Vaughan TL, Storer BE, Haggitt RC, Rabinovitch PS, Levine DS, Reid BJ, Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus, Annals of Internal Medicine, 132(8), 612-20, April 2000 Abstract
  • Strasser SI, Myerson D, Spurgeon CL, Sullivan KM, Storer B, Schoch HG, Kim S, Flowers ME, McDonald GB, Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up, Hepatology, 29(6), 1893-9, June 1999 Abstract
  • Strasser SI, Sullivan KM, Myerson D, Spurgeon CL, Storer B, Schoch HG, Murakami CS, McDonald GB, Cirrhosis of the liver in long-term marrow transplant survivors, Blood, 93(10), 3259-66, May 1999 Abstract
  • Gooley TA, Leisenring W, Crowley J, Storer BE, Estimation of failure probabilities in the presence of competing risks: new representations of old estimators, Statistics in Medicine, 18(6), 695-706, March 1999 Abstract
  • Bavisotto LM, Patel NH, Althaus SJ, Coldwell DM, Nghiem HV, Thompson T, Storer B, Thomas CR Jr, Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the, Clinical Cancer Research, 5(1), 95-109, Jan 1999 Abstract
  • Berlin J, Stewart JA, Storer B, Tutsch KD, Arzoomanian RZ, Alberti D, Feierabend C, Simon K, Wilding G, Phase I clinical and pharmacokinetic trial of penclomedine using a novel, two-stage trial design for patients with advanced malignancy, Journal of Clinical Oncology, 16(3), 1142-9, March 1998 Abstract
  • Shoff SM, Newcomb PA, Mares-Perlman JA, Klein BE, Haffner SM, Storer BE, Klein R, Usual consumption of plant foods containing phytoestrogens and sex hormone levels in postmenopausal women in Wisconsin, Nutrition and Cancer, 30(3), 207-12, 1998 Abstract
  • Sullivan KM, Kansu E, Storer B, Jocom J, Emerson G, Reagan T, Emerson V, Siadak MF, Davis C, Appelbaum FR, Buckner CD, Hansen JA, Shulman HM, Storb R, McDonald GB, Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation, Biology of Blood and Marrow Transplantation, 4(1), 20-6, 1998 Abstract
  • Storer B (1998) Phase I trials, Encyclopedia of Biostatistics, New York, Wiley, 3365-3370 pages (bookchapter)
  • Newcomb PA, Trentham-Dietz A, Storer BE, Alcohol consumption in relation to endometrial cancer risk, Cancer Epidemiology, Biomarkers and Prevention, 6(10), 775-8, October 1997 Abstract
  • Tannehill SP, Mehta MP, Larson M, Storer B, Pellet J, Kinsella TJ, Schiller JH, Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: results of a phase II trial, Journal of Clinical Oncology, 15(8), 2850-7, August 1997 Abstract
  • Albertini MR, Hank JA, Schiller JH, Khorsand M, Borchert AA, Gan J, Bechhofer R, Storer B, Reisfeld RA, Sondel PM, Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients, Clinical Cancer Research, 3(8), 1277-88, August 1997 Abstract
  • Wittenkeller JL, Storer B, Bittner G, Schiller JH, Comparison of spontaneous and induced mutation rates in an immortalized human bronchial epithelial cell line and its tumorigenic derivative, Oncology, 54(4), 335-41, 1997 Abstract
  • Sierra J, Storer B, Hansen JA, Bjerke JW, Martin PJ, Petersdorf EW, Appelbaum FR, Bryant E, Chauncey TR, Sale G, Sanders JE, Storb R, Sullivan KM, Anasetti C, Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose, Blood, 89(11), 4226-35, June 1997 Abstract
  • Slattery JT, Clift RA, Buckner CD, Radich J, Storer B, Bensinger WI, Soll E, Anasetti C, Bowden R, Bryant E, Chauncey T, Deeg HJ, Doney KC, Flowers M, Gooley T, Hansen JA, Martin PJ, McDonald GB, Nash R, Petersdorf EW, Sanders JE, Schoch G, Stewart P, Storb R, Appelbaum FR, Et Al. (Apr 1997) Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation., Blood, 89 (8), 3055-60 Abstract
  • Newcomb PA, Trentham-Dietz A, Storer BE, Parental age in relation to risk of breast cancer, Cancer Epidemiology, Biomarkers and Prevention, 6(3), 151-4, March 1997 Abstract
  • Demirer T, Buckner CD, Storer B, Lilleby K, Rowley S, Clift R, Appelbaum FR, Storb R, Bensinger WI, Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor, Journal of Clinical Oncology, 15(2), 684-90, February 1997 Abstract
  • Cleary JF, Arzoomanian R, Alberti D, Feierabend C, Storer B, Witt P, Carbone P, Wilding G, A phase I study of 5-fluorouracil, leucovorin and levamisole, Cancer Chemotherapy and Pharmacology, 39(4), 300-6, 1997 Abstract
  • Reeves MJ, Newcomb PA, Trentham-Dietz A, Storer BE, Remington PL, Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women, Cancer Epidemiology, Biomarkers and Prevention, 5(12), 955-60, December 1996 Abstract
  • Fryback DG, Albertsen PC, Storer BE, Prostatectomy and survival among men with clinically localized prostate cancer., Jama : the Journal of the American Medical Association, 276(21), 1723-4; author reply, Dec 1996 Abstract
  • Newcomb PA, Longnecker MP, Storer BE, Mittendorf R, Baron J, Clapp RW, Trentham-Dietz A, Willett WC, Recent oral contraceptive use and risk of breast cancer (United States), Cancer Causes and Control, 7(5), 525-32, September 1996 Abstract
  • Albertini MR, Gan J, Jaeger P, Hank JA, Storer B, Schell K, Rivest T, Surfus J, Reisfeld RA, Schiller JH, Sondel PM, Systemic interleukin-2 modulates the anti-idiotypic response to chimeric anti-GD2 antibody in patients with melanoma, Journal of Immunotherapy With Emphasis On Tumor Immunology, 19(4), 278-95, July 1996 Abstract
  • Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J, The impact of co-morbidity on life expectancy among men with localized prostate cancer, Journal of Urology, 156(1), 127-32, July 1996 Abstract
  • Schiller JH, Storer B, Berlin J, Wittenkeller J, Larson M, Pharo L, Larson M, Berry W, Amifostine, cisplatin, and vinblastine in metastatic non-small-cell lung cancer: a report of high response rates and prolonged survival, Journal of Clinical Oncology, 14(6), 1913-21, June 1996 Abstract
  • Baron JA, Newcomb PA, Longnecker MP, Mittendorf R, Storer BE, Clapp RW, Bogdan G, Yuen J, Cigarette smoking and breast cancer, Cancer Epidemiology, Biomarkers and Prevention, 5(5), 399-403, May 1996 Abstract
  • Wiedemann GJ, Robins HI, Gutsche S, Mentzel M, Deeken M, Katschinski DM, Eleftheriadis S, Crahe R, Weiss C, Storer B, Wagner T, Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8 degrees C whole body hyperthermia in patients with refractory sarcoma, European Journal of Cancer, 32A(5), 888-92, May 1996 Abstract
  • Roberts FD, Newcomb PA, Trentham-Dietz A, Storer BE, Self-reported stress and risk of breast cancer, Cancer, 77(6), 1089-93, March 1996 Abstract
  • Schiller JH, Hank JA, Khorsand M, Storer B, Borchert A, Huseby-Moore K, Burns D, Wesly O, Albertini MR, Wilding G, Sondel PM, Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB study, Clinical Cancer Research, 2(2), 319-30, February 1996 Abstract
  • Newcomb PA, Storer BE, Longnecker MP, Mittendorf R, Greenberg ER, Willett WC, Pregnancy termination in relation to risk of breast cancer, Jama, 275(4), 283-7, January 1996 Abstract
  • Storer BE, Newcomb PA, Longnecker MP (1996) Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women (Letter to the Editor), American Journal of Epidemiology, 144 (8), 798-799
  • Newcomb PA, Storer BE, Longnecker MP (1996) Pregnancy termination and risk of breast cancer (Letter to the Editor), Journal of the American Medical Association, 276 (1), 31-32
  • Newcomb PA, Storer BE, Marcus PM, Cigarette smoking in relation to risk of large bowel cancer in women, Cancer Research, 55(21), 4906-9, November 1995 Abstract
  • Newcomb PA, Longnecker MP, Storer BE, Mittendorf R, Baron J, Clapp RW, Bogdan G, Willett WC, Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women [see comments] [published erratum appears in Am J Epidemiol 1996 Mar 1, American Journal of Epidemiology, 142(8), 788-95, October 1995 Abstract
  • Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J, Long-term survival among men with conservatively treated localized prostate cancer, Jama, 274(8), 626-31, August 1995 Abstract
  • Marcus PM, Newcomb PA, Young T, Storer BE, The association of reproductive and menstrual characteristics and colon and rectal cancer risk in Wisconsin women, Annals of Epidemiology, 5(4), 303-9, July 1995 Abstract
  • Dietz AT, Newcomb PA, Storer BE, Longnecker MP, Mittendorf R, Multiple births and risk of breast cancer, International Journal of Cancer, 62(2), 162-4, July 1995 Abstract
  • Newcomb PA, Storer BE, Postmenopausal hormone use and risk of large-bowel cancer [published erratum appears in J Natl Cancer Inst 1995 Sep 20, Journal of the National Cancer Institute, 87(14), 1067-71, July 1995 Abstract
  • Newcomb PA, Olsen SJ, Roberts FD, Storer BE, Love RR, Assessing breast self-examination, Preventive Medicine, 24(3), 255-8, May 1995 Abstract
  • Hank JA, Albertini M, Wesly OH, Schiller JH, Borchert A, Moore K, Bechhofer R, Storer B, Gan J, Gambacorti C, et al, Clinical and immunological effects of treatment with murine anti-CD3 monoclonal antibody along with interleukin 2 in patients with cancer, Clinical Cancer Research, 1(5), 481-91, May 1995 Abstract
  • Dietz AT, Newcomb PA, Marcus PM, Storer BE, The association of body size and large bowel cancer risk in Wisconsin (United States) women, Cancer Causes and Control, 6(1), 30-6, January 1995 Abstract
  • Marcus PM, Newcomb PA, Storer BE, Early adulthood physical activity and colon cancer risk among Wisconsin women, Cancer Epidemiology, Biomarkers and Prevention, 3(8), 641-4, December 1994 Abstract
  • Schiller JH, Storer B, Tutsch K, Arzoomanian R, Alberti D, Feierabend C, Spriggs D, A phase I trial of 3-hour infusions of paclitaxel (Taxol) with or without granulocyte colony-stimulating factor, Seminars in Oncology, 21(5 Suppl 8), 9-14, October 1994 Abstract
  • Malkovska V, Cigel F, Storer BE, Human T cells in hu-PBL-SCID mice proliferate in response to Daudi lymphoma and confer anti-tumour immunity, Clinical and Experimental Immunology, 96(1), 158-65, April 1994 Abstract
  • Schiller JH, Storer B, Tutsch K, Arzoomanian R, Alberti D, Feierabend C, Spriggs D, Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer [see comments], Journal of Clinical Oncology, 12(2), 241-8, February 1994 Abstract
  • Newcomb PA, Storer BE, Longnecker MP, Mittendorf R, Greenberg ER, Clapp RW, Burke KP, Willett WC, MacMahon B, Lactation and a reduced risk of premenopausal breast cancer, New England Journal of Medicine, 330(2), 81-7, January 1994 Abstract
  • Newcomb PA, Storer BE, Longnecker MP (1994) Breast feeding and breast cancer (Letter to the Editor), New England Journal of Medicine, 330, 1684
  • Storer BE, Small-sample confidence sets for the MTD in a phase I clinical trial, Biometrics, 49(4), 1117-25, December 1993 Abstract
  • Schiller JH, Storer B, Arzoomanian R, Tutsch K, Alberti D, Spriggs D, Phase I trial of mitoxantrone and granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced solid malignancies, Investigational New Drugs, 11(4), 291-300, November 1993 Abstract
  • Newcomb PA, Storer BE, Marcus PM, Cancer of the large bowel in women in relation to alcohol consumption: a case-control study in Wisconsin (United States), Cancer Causes and Control, 4(5), 405-11, September 1993 Abstract
  • Witt PL, Storer BE, Bryan GT, Brown RR, Flashner M, Larocca AT, Colby CB, Borden EC, Pharmacodynamics of biological response in vivo after single and multiple doses of interferon-beta, Journal of Immunotherapy, 13(3), 191-200, April 1993 Abstract
  • Schiller JH, Hank J, Storer B, Borchert AA, Moore KH, Albertini M, Bechhofer R, Wesley O, Brown RR, Bastin AM, et al, A direct comparison of immunological and clinical effects of interleukin 2 with and without interferon-alpha in humans, Cancer Research, 53(6), 1286-92, March 1993 Abstract
  • Arbaje YM, Bittner G, Yingling JM, Storer B, Schiller JH, Antiproliferative effects of interferons -alpha and -beta in combination with 5-fluorouracil, cisplatin, and cis- and trans-retinoic acid in three human lung carcinoma cell lines, Journal of Interferon Research, 13(1), 25-32, February 1993 Abstract
  • Gambacorti-Passerini C, Hank JA, Albertini MR, Borchert AA, Moore KH, Schiller JH, Bechhofer R, Borden EC, Storer B, Sondel PM, A pilot phase II trial of continuous-infusion interleukin-2 followed by lymphokine-activated killer cell therapy and bolus-infusion interleukin-2 in renal cancer, Journal of Immunotherapy, 13(1), 43-8, January 1993 Abstract
  • Witt PL, Goldstein D, Storer BE, Grossberg SE, Flashner M, Colby CB, Borden EC, Absence of biological effects of orally administered interferon-beta ser, Journal of Interferon Research, 12(6), 411-3, December 1992 Abstract
  • Malkovska V, Cigel FK, Armstrong N, Storer BE, Hong R, Antilymphoma activity of human gamma delta T-cells in mice with severe combined immune deficiency, Cancer Research, 52(20), 5610-6, October 1992 Abstract
  • Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM, Screening sigmoidoscopy and colorectal cancer mortality, Journal of the National Cancer Institute, 84(20), 1572-5, October 1992 Abstract
  • Storer BE, A class of phase II designs with three possible outcomes, Biometrics, 48(1), 55-60, March 1992 Abstract
  • Schiller JH, Witt PL, Storer B, Alberti D, Tombes MB, Arzoomanian R, Brown RR, Proctor RA, Voss SD, Spriggs DR, et al, Clinical and biologic effects of combination therapy with gamma-interferon and tumor necrosis factor, Cancer, 69(2), 562-71, January 1992 Abstract
  • Wu SQ, Storer BE, Bookland EA, Klingelhutz AJ, Gilchrist KW, Meisner LF, Oyasu R, Reznikoff CA, Nonrandom chromosome losses in stepwise neoplastic transformation in vitro of human uroepithelial cells, Cancer Research, 51(12), 3323-6, June 1991 Abstract
  • Schiller JH, Storer BE, Witt PL, Alberti D, Tombes MB, Arzoomanian R, Proctor RA, McCarthy D, Brown RR, Voss SD, et al, Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly, Cancer Research, 51(6), 1651-8, March 1991 Abstract
  • Newcomb PA, Weiss NS, Storer BE, Scholes D, Young BE, Voigt LF, Breast self-examination in relation to the occurrence of advanced breast cancer, Journal of the National Cancer Institute, 83(4), 260-5, February 1991 Abstract
  • Sosman JA, Hank JA, Moore KH, Borchert A, Schell K, Kohler PC, Goldstein D, Bechhofer R, Storer B, Albertini MR, et al, Prolonged interleukin-2 (IL-2) treatment can augment immune activation without enhancing antitumor activity in renal cell carcinoma, Cancer Investigation, 9(1), 35-48, 1991 Abstract
  • Borden EC, Rinehart JJ, Storer BE, Trump DL, Paulnock DM, Teitelbaum AP, Biological and clinical effects of interferon-beta ser at two doses, Journal of Interferon Research, 10(6), 559-70, December 1990 Abstract
  • Albertini MR, Sosman JA, Hank JA, Moore KH, Borchert A, Schell K, Kohler PC, Bechhofer R, Storer B, Sondel PM, The influence of autologous lymphokine-activated killer cell infusions on the toxicity and antitumor effect of repetitive cycles of interleukin-2, Cancer, 66(12), 2457-64, December 1990 Abstract
  • Schiller JH, Storer B, Paulnock DM, Brown RR, Datta SP, Witt PL, Borden EC, A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans, Journal of Clinical Investigation, 86(4), 1211-21, October 1990 Abstract
  • Schiller JH, Storer B, Witt PL, Nelson B, Brown RR, Horisberger M, Grossberg S, Borden EC, Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion, Cancer Research, 50(15), 4588-94, August 1990 Abstract
  • Schiller JH, Horisberger MA, Bittner G, Carlin JM, Storer B, Byrne GI, Willson JK, Borden EC, Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle, Journal of Biological Response Modifiers, 9(4), 368-77, August 1990 Abstract
  • Schiller JH, Storer B, Bittner G, Horisberger MA, Characterization of the synergistic antiproliferative effects of interferon-gamma and tumor necrosis factor on human colon carcinoma cell lines, Journal of Interferon Research, 10(2), 129-39, April 1990 Abstract
  • Storer BE, A sequential phase II/III trial for binary outcomes, Statistics in Medicine, 9(3), 229-35, March 1990 Abstract
  • Hank JA, Sosman JA, Kohler PC, Bechhofer R, Storer B, Sondel PM, Depressed in vitro T cell responses concomitant with augmented interleukin-2 responses by lymphocytes from cancer patients following in vivo treatment with interleukin-2, Journal of Biological Response Modifiers, 9(1), 5-14, February 1990 Abstract
  • Storer BE, Kim C (1990) Exact properties of some exact test statistics for comparing two binomial proportions, Journal of the American Statistical Association, 85 (409), 146-155
  • Schiller JH, Ritch PS, Storer B, Trump DL, A pilot study of short-course, high-dose cytosine arabinoside, etoposide, and cisplatin in refractory, aggressive-histology, non-Hodgkin's lymphomas, American Journal of Clinical Oncology, 12(6), 502-6, December 1989 Abstract
  • Goldstein D, Sosman JA, Hank JA, Weil-Hillman G, Moore KH, Borchert A, Bechhofer R, Storer B, Kohler PC, Levitt D, et al, Repetitive weekly cycles of interleukin 2: effect of outpatient treatment with a lower dose of interleukin 2 on non-major histocompatibility complex-restricted killer activity, Cancer Research, 49(23), 6832-9, December 1989 Abstract
  • Schiller JH, Storer B, Dreicer R, Rosenquist D, Frontiera M, Carbone PP, Randomized phase II-III trial of combination beta and gamma interferons and etoposide and cisplatin in inoperable non-small cell cancer of the lung, Journal of the National Cancer Institute, 81(22), 1739-43, November 1989 Abstract
  • Storer BE, Design and analysis of phase I clinical trials, Biometrics, 45(3), 925-37, September 1989 Abstract
  • Brown RR, Lee CM, Kohler PC, Hank JA, Storer BE, Sondel PM, Altered tryptophan and neopterin metabolism in cancer patients treated with recombinant interleukin 2, Cancer Research, 49(17), 4941-4, September 1989 Abstract
  • Paulnock DM, Havlin KA, Storer BM, Spear GT, Sielaff KM, Borden EC, Induced proteins in human peripheral mononuclear cells over a range of clinically tolerable doses of interferon-gamma, Journal of Interferon Research, 9(4), 457-73, August 1989 Abstract
  • Goldstein D, Sielaff KM, Storer BE, Brown RR, Datta SP, Witt PL, Teitelbaum AP, Smalley RV, Borden EC, Human biologic response modification by interferon in the absence of measurable serum concentrations: a comparative trial of subcutaneous and intravenous interferon-beta serine, Journal of the National Cancer Institute, 81(14), 1061-8, July 1989 Abstract
  • Sondel PM, Sosman JA, Hank JA, Kohler PC, Storer B, Tumor-infiltrating lymphocytes and interleukin-2 in melanomas., The New England Journal of Medicine, 320(21), 1418-9, May 1989 Abstract
  • Robins HI, Sielaff KM, Storer B, Hawkins MJ, Borden EC, Phase I trial of human lymphoblastoid interferon with whole body hyperthermia in advanced cancer, Cancer Research, 49(6), 1609-15, March 1989 Abstract
  • Kohler PC, Hank JA, Moore KH, Storer B, Bechhofer R, Hong R, Sondel PM, Phase 1 clinical trial of recombinant interleukin-2: a comparison of bolus and continuous intravenous infusion, Cancer Investigation, 7(3), 213-23, 1989 Abstract
  • Witt PL, Storer BE, Helgeson DO, Borden EC (1989) Interferon-induced proteins in clinical trials: 2',5'-oligoadenylate synthetase as a prototype, The Biology of the Interferon System, Tokyo, Kodansha Scientific Press, 195-200 pages (bookchapter)
  • Sosman JA, Kohler PC, Hank JA, Moore KH, Bechhofer R, Storer B, Sondel PM, Repetitive weekly cycles of interleukin-2. II. Clinical and immunologic effects of dose, schedule, and addition of indomethacin, Journal of the National Cancer Institute, 80(18), 1451-61, November 1988 Abstract
  • Schiller JH, Storer B, Bittner G, Willson JK, Borden EC, Phase II trial of a combination of interferon-beta ser and interferon-gamma in patients with advanced malignant melanoma, Journal of Interferon Research, 8(5), 581-9, October 1988 Abstract
  • Borden EC, Hawkins MJ, Sielaff KM, Storer BM, Schiesel JD, Smalley RV, Clinical and biological effects of recombinant interferon-beta administered intravenously daily in phase I trial [published erratum appears in J Interferon Res 1988 Oct, Journal of Interferon Research, 8(3), 357-66, June 1988 Abstract
  • Sondel PM, Kohler PC, Hank JA, Moore KH, Rosenthal NS, Sosman JA, Bechhofer R, Storer B, Clinical and immunological effects of recombinant interleukin 2 given by repetitive weekly cycles to patients with cancer, Cancer Research, 48(9), 2561-7, May 1988 Abstract
  • Rosenthal NS, Hank JA, Kohler PC, Minkoff DZ, Moore KH, Bechhofer R, Hong R, Storer B, Sondel PM, The in vitro function of lymphocytes from 25 cancer patients receiving four to seven consecutive days of recombinant IL-2, Journal of Biological Response Modifiers, 7(2), 123-39, April 1988 Abstract
  • Hank JA, Kohler PC, Weil-Hillman G, Rosenthal N, Moore KH, Storer B, Minkoff D, Bradshaw J, Bechhofer R, Sondel PM, In vivo induction of the lymphokine-activated killer phenomenon: interleukin 2-dependent human non-major histocompatibility complex-restricted cytotoxicity generated in vivo during administration of h, Cancer Research, 48(7), 1965-71, April 1988 Abstract
  • Sosman JA, Kohler PC, Hank J, Moore KH, Bechhofer R, Storer B, Sondel PM, Repetitive weekly cycles of recombinant human interleukin-2: responses of renal carcinoma with acceptable toxicity, Journal of the National Cancer Institute, 80(1), 60-3, March 1988 Abstract
  • Thompson RS, Michnich ME, Friedlander L, Gilson B, Grothaus LC, Storer B, Effectiveness of smoking cessation interventions integrated into primary care practice, Medical Care, 26(1), 62-76, January 1988 Abstract
  • Schiller JH, Storer B, Willson JK, Borden EC, Phase I trial of combinations of recombinant interferons beta(ser) and gamma in patients with advanced malignancy, Cancer Treatment Reports, 71(10), 945-52, October 1987 Abstract
  • Rosenzweig IB, Wiebe DA, Borden EC, Storer B, Shrago ES, Plasma lipoprotein changes in humans induced by beta-interferon, Atherosclerosis, 67(2-3), 261-7, October 1987 Abstract
  • Trump DL, Grem JL, Tutsch KD, Willson JK, Simon KJ, Alberti D, Storer B, Tormey DC, Platinum analogue combination chemotherapy: cisplatin and carboplatin--a phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carboplatin excretion, Journal of Clinical Oncology, 5(8), 1281-9, August 1987 Abstract
  • Schiller JH, Bittner G, Storer B, Willson JK, Synergistic antitumor effects of tumor necrosis factor and gamma-interferon on human colon carcinoma cell lines, Cancer Research, 47(11), 2809-13, June 1987 Abstract
  • Kohler PC, Hank JA, Moore KH, Storer B, Bechhofer R, Sondel PM, Phase 1 clinical evaluation of recombinant interleukin-2, Progress in Clinical and Biological Research, 244, 161-72, 1987 Abstract
  • Sondel PM, Hank JA, Rosenthal N, Moore KH, Hong R, Storer B, Kohler PC, Clinical testing of IL-2: in vivo administration of IL-2 induces IL-2 dependent non-MHC-restricted cytotoxicity (NRC), Progress in Clinical and Biological Research, 244, 173-84, 1987 Abstract
  • Sondel PM, Hank JA, Rosenthal N, Moore KH, Hong R, Storer B, Kohler PC (1987) Clinical testing of IL-2: In vivo administreation of IL-2 induces IL-2 dependent non-MHC-restricted cytotoxicity, Cellular Immunotherapy of Cancer, New York, Alan R. Liss, 173-184 pages (bookchapter)
  • Kohler PC, Hank JA, Moore KH, Storer B, Bechhofer R, Sondel PM (1987) Phase I clinical evaluation of recombinant Interleukin-2, Cellular Immunotherapy of Cancer, New York, Alan R. Liss, 161-172 pages (bookchapter)
  • Breslow NE, Storer BE, General relative risk functions for case-control studies, American Journal of Epidemiology, 122(1), 149-62, July 1985 Abstract
  • Bonadio JF, Storer B, Norkool P, Farewell VT, Beckwith JB, D'Angio GJ, Anaplastic Wilms' tumor: clinical and pathologic studies, Journal of Clinical Oncology, 3(4), 513-20, April 1985 Abstract
  • Thomas PR, Tefft M, Farewell VT, Norkool P, Storer B, D'Angio GJ (Oct 1984) Abdominal relapses in irradiated second National Wilms' Tumor Study patients., Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 2 (10), 1098-101 Abstract
  • Lee JA, Storer BE (Jun 1982) Further studies on skin melanomas apparently dependent on female sex hormones., International Journal of Epidemiology, 11 (2), 127-31 Abstract
  • Lee JA, Storer BE, Malignant melanoma female/male death ratios., Lancet, 1(8235), 1419, Jun 1981 Abstract
  • Lee JA, Storer BE (Dec 1980) Excess of malignant melanomas in women in the British Isles., Lancet, 2 (8208-8209), 1337-9 Abstract

Profile Details

Last Verified: 11/16/2006

COS Expertise ID #901093
Reference this profile directly: http://myprofile.cos.com/storerab2